Skip to main content

Table 1 Laboratory data (Blood. Age 36 years)

From: Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant

VariablesValuesNormal range
Fasting glucose, mmol/l8.83.1–6.1
HbA1c, %7.34–6
C-peptide, ng/ml0.9281.1–4.4
Anti-tyrosine phosphatase antibodies, U/ml0.144neg. < 8
Anti-islet cell antibodies, U/ml0.58neg. < 0.95
Anti-insulin antibodies, U/ml17pos. > 10
Zinc transporter 8 antibodies, U/ml1.436neg. < 15
Anti-GAD antibodies, U/ml0.7neg. < 1
Total cholesterol, mmol/l5.553.3–5.2
HDL cholestrol, mmol/l0.4521.15–2.6
LDL cholestrol, mmol/l1.4351.1–3
Triglycerides, mmol/l8.140.1–1.7
Leptin, ng/ml5.3823.7–11.1
Adiponectin, ng/ml2.548.2–19
Creatinine kinase, U/l47229–168
ALT, U/l420–55
AST, U/l755–34
GGT, U / l,1399–36
Calcium, mmol/l2.282.15–2.55
Ionized calcium, mmol/l0.91.03–1.29
Vitamin D, ng / ml27.2> 30
Creatinine, mcmol/l69.250–98
CKD – EPI, ml/min/1,73 m29890–120
Urea, mmol/l9.42.5–6.7
Uric acid, μmol444.25142–339
  1. HbA1c Hemoglobin A1c, GAD Glutamic acid decarboxylase, HDL High-density lipoprotein, LDL Low-density lipoprotein, ALT Alanine aminotransferase, AST Aspartate aminotransferase, GGT Gamma-glutamyl transpeptidase, CKD – EPI Chronic Kidney Disease Epidemiology Collaboration